Marta González-Álvarez (Marta Gonzalez-Alvarez)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Benign Prostatic Hyperplasia

Metastatic Breast Cancer

Top Venues

Molecular pharmaceutics

Nanomedicine (London, England)

Animals : an open access journal from MDPI

This page only lists publications with an associated author ORCID identifier.

Publications

Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Gema J Cabañero-Resta, Bárbara Sánchez-Dengra, Alejandro Ruiz-Picazo, Marival Bermejo, Virginia Merino, Isabel González-Álvarez, Marta González-Álvarez
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. Pharmaceutics 16 (5) (2024)
Gema J Cabañero-Resta, Bárbara Sánchez-Dengra, Alejandro Ruiz-Picazo, Marival Bermejo, Virginia Merino, Isabel González-Álvarez, Marta González-Álvarez
Pharmaceutical Compounding in Veterinary Medicine: Suspension of Itraconazole. Pharmaceutics 16 (5) (2024)
Isabel González-Álvarez, Alejandro Ruiz-Picazo, Ruben Selles-Talavera, Andres Figueroa-Campos, Virginia Merino, Marival Bermejo, Marta González-Álvarez
In Vivo Predictive Dissolution and Biopharmaceutic-Based In Silico Model to Explain Bioequivalence Results of Valsartan, a Biopharmaceutics Classification System Class IV Drug. Pharmaceutics 16 (3) (2024)
Bárbara Sánchez-Dengra, Elena García-Montoya, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez
Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood-Brain Barrier in Patients with Glioblastoma. Pharmaceutics 15 (5) (2023)
Bárbara Sánchez-Dengra, María Alfonso, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez, Ramón Martínez-Máñez
Intranasal administration of molecular-gated mesoporous nanoparticles to increase ponatinib delivery to the brain. Nanomedicine (London, England) (2023)
Claudia Miranda, Alejandro Ruiz-Picazo, Paula Pomares, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez, Alex Avdeef, Miguel Ángel Cabrera-Pérez
Integration of In Silico, In Vitro and In Situ Tools for the Preformulation and Characterization of a Novel Cardio-Neuroprotective Compound during the Early Stages of Drug Development. Pharmaceutics 14 (1) (2022)
Emre Ozgenc, Merve Karpuz, Ege Arzuk, Marta González-Álvarez, Marival Bermejo Sanz, Evren Gundogdu, Isabel González-Álvarez
Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies. ACS omega 7 (34) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Isabel González-Álvarez, Bárbara Sánchez-Dengra, Raquel Rodriguez-Galvez, Alejandro Ruiz-Picazo, Marta González-Álvarez, Alfredo Garcia-Arieta, Marival Bermejo
Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients. Pharmaceutics 14 (12) (2022)
Bárbara Sánchez-Dengra, Isabel González-Álvarez, Marival Bermejo, Marta González-Álvarez
Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat. Pharmaceutics 13 (9) (2021)
Isabel González-Álvarez, Marival Bermejo, Yasuhiro Tsume, Alejandro Ruiz-Picazo, Marta González-Álvarez, Bart Hens, Alfredo Garcia-Arieta, Greg E Amidon, Gordon L Amidon
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products. Pharmaceutics 13 (4) (2021)
Elisa Poyatos-Racionero, Isabel González-Álvarez, Juan A Marchal, Leopoldo Sitia, Francesca Gatto, Pier Paolo Pompa, Elena Aznar, Marta González-Álvarez, Ramón Martínez-Máñez, María Dolores Marcos, Andrea Bernardos
Lactose-Gated Mesoporous Silica Particles for Intestinal Controlled Delivery of Essential Oil Components: An In Vitro and In Vivo Study. Pharmaceutics 13 (7) (2021)
Marta González-Álvarez
Controlled Delivery Formulations. Pharmaceutics 13 (3) (2021)
Bárbara Sánchez-Dengra, Isabel González-Álvarez, Marta González-Álvarez, Marival Bermejo
New In Vitro Methodology for Kinetics Distribution Prediction in the Brain. An Additional Step towards an Animal-Free Approach. Animals : an open access journal from MDPI 11 (12) (2021)
Alejandro Ruiz-Picazo, Marta González-Álvarez, Isabel González-Álvarez, Marival Bermejo
Effect of Common Excipients on Intestinal Drug Absorption in Wistar Rats. Molecular pharmaceutics 17 (7) (2020)
Adrián H Teruel, Édgar Pérez-Esteve, Isabel González-Álvarez, Marta González-Álvarez, Ana M Costero, Daniel Ferri, Pablo Gaviña, Virginia Merino, Ramón Martínez-Máñez, Félix Sancenón
Double Drug Delivery Using Capped Mesoporous Silica Microparticles for the Effective Treatment of Inflammatory Bowel Disease. Molecular pharmaceutics 16 (6) (2019)